Please ensure Javascript is enabled for purposes of website accessibility
ホーム > 製品 > 抗体 > バイオシミラー

Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO) (HV974216)

Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO)
Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO)
Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO)
Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO)
Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO)
Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO)
Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO)
Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO)
価格(USD):
スペック:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
数量:
お問い合わせ
  • 概要

  • イメージ

  • 参考文献

  • データシート

  • SDS

概要
カタログ番号HV974216
説明
Reozalimab (HV974216) is a research-grade recombinant antibody targeting CD1. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
種反応性Human
アプリケーションELISA, Bioactivity: FCM, Functional assay, Research in vivo
宿主種Human
クローン性Monoclonal
アイソタイプIg(G1-kappa_G1-lambda2)
テスト済みアプリケーション WB, FCM
ターゲット B7 homolog 1, B7-H1, B7H1, CD274, PD-L1, PDCD1 ligand 1, PDCD1L1, PDCD1LG1, PDL1, Programmed cell death 1 ligand 1, Programmed death ligand 1, CD279, PD1, PDCD1, Programmed cell death protein 1, Protein PD-1
エンドトキシンレベル < 10 EU/mg
純度 >95% as determined by SDS-PAGE.
精製 Protein A/G purified from cell culture supernatant.
アクセッション番号 Q9NZQ7 & Q15116
形態 Liquid
保存バッファー 0.01M PBS pH 7.4.

データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。

安定性と保存 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
別名Bispecific, IBI318, IBI-318, IBI318, 2445259-99-2
背景Reozalimab is a bispecific antibody targeting to PD-1/PD-L1. Reozalimab mediates antibody-dependent cell cytotoxicity in cancer research.
注意事項 For research use only. Not suitable for clinical or therapeutic use.
イメージ
  • Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO)

    Bioactivity

    Detects PDL1 in indirect ELISA.

  • Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO)

    Bioactivity

    Detects recombinant human PD1 (Cat No.: HS870021) in indirect ELISA.

  • Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO)

    Flow CytoMetry

    Flow-cytometry using anti-human CD274 antibody. Untransfected cells (blue Histogram) and Transfected cells (Yellow Histogram) were stained with an anti-human CD274 monoclonal antibody (Catalog: HV974216) at a concentration of 5 µg/ml for 30 mins at RT. After washing, bound antibody was detected using a Goat Anti-Human IgG H&L Polyclonal Antibody, FITC (abinScience: HF690414) and cells analysed on a NovoCyte Flow Cytometer.

  • Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO)

    Western blot

    Western blot analysis was performed using anti-CD274/PD-L1/B7-H1 monoclonal antibody at 1ug/mL on various samples.
    Lane 1: recombinant human CD274/PD-L1/B7-H1 (Catalog No: HV974011)
    Lane 2: negative control

参考文献
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
レコメンデーション

お問い合わせ カスタムクォート、大量リクエストおよびその他の問題については

メール: [email protected]

ディストリビューターリスト